Business Model Breakdown
How Hims & Hers Health Inc Makes Money
HIMS
Market Cap
$6.5B
Annual Revenue
$2.3B
Profit Margin
-0.6%
Employees
1,637
The Short Version
Hims & Hers operates a direct-to-consumer telehealth platform that connects individuals with licensed healthcare professionals for consultations and facilitates the dispensing of prescription and over-the-counter medications. It primarily offers subscription-based access to personalized care across various conditions, including sexual health, hair loss, mental health, and increasingly, weight management, aiming to make healthcare more accessible and affordable.
Where the Revenue Comes From
Subscription fees for consultations and medication fulfillment (primary, but specific % not provided)
Product sales (secondary, specific % not provided)
Who buys: Individual consumers seeking accessible, convenient, and often discreet healthcare services for a range of health and wellness needs.
Why It Works (Competitive Advantages)
- ✔Strong brand recognition ('Hims' and 'Hers') in specific direct-to-consumer health niches.
- ✔Vertically integrated pharmacy and telehealth platform offering end-to-end care.
- ✔Early mover advantage and strong execution in the personalized digital health space.
Economic Moat: Narrow (Brand Power, Switching Costs, Intangible Assets/IP)
What Our Analysis Says
DVR Score as of June 5, 2026
Hims & Hers is strategically executing its pivot into high-growth chronic care, especially weight loss, and expanding internationally, reinforced by the completed Eucalyptus acquisition and the hiring of a new CMO. The recent $350M convertible notes offer significant capital for growth initiatives, managed with capped calls to mitigate dilution. While Q1 2026 saw a decline in gross margin (65% vs 73% YoY), the company maintained positive free cash flow ($53M) and reaffirmed raised FY2026 guidance. The potential for 10x growth within 3-5 years hinges on successfully scaling these new ventures and improving operating leverage amidst intense competition.